{"schema_version":"secwatch.filing_event.v1","accession":"0001145197-23-000058","form_type":"8-K","ticker":"PODD","cik":"0001145197","company_name":"INSULET CORP","filed_at":"2023-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.243460+00:00","generated_at":"2026-06-12T00:42:32.104961+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Insulet Q2 revenue up 32% to $396.5M; net income $27.3M vs prior year loss","bullets":["Total revenue $396.5M, +32.4% YoY; Omnipod revenue $380.5M (+33.2%).","U.S. Omnipod revenue $276.8M (+40.9%); International Omnipod $103.7M (+16.0%).","Net income $27.3M ($0.39 diluted EPS) vs net loss of $35.0M ($0.50 loss) in prior year.","Adjusted EBITDA $61.3M (15.5% of revenue) vs $27.6M (9.2%) prior year.","Launched Omnipod 5 in UK; submitted Omnipod 5 iOS App to FDA for clearance."],"urls":{"canonical":"https://secwatch.observer/filing/0001145197-23-000058","json":"https://secwatch.observer/filing/0001145197-23-000058.json","markdown":"https://secwatch.observer/filing/0001145197-23-000058.md","text":"https://secwatch.observer/filing/0001145197-23-000058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1145197/000114519723000058/0001145197-23-000058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1145197/000114519723000058/podd-20230808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T00:42:32.104961+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}